PUBLIC COMPANY
saveIntraBio Ltd
updated 2mo ago
community read0 votes
pipeline
1
marketed
1
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Marketed
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase3A Pivotal Study of N-Acetyl-L-Leucine on Niemann-Pick Disease Type C
- phase3Pivotal Study of N-acetyl-L-leucine for CACNA1A
- phase2N-Acetyl-L-Leucine for Ataxia-Telangiectasia (A-T)
- —Expanded Access Program (EAP) of Levacetylleucine for Ataxia-Telangiectasia (A-T)
- phase3A Pivotal Study of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T)
- phase2N-Acetyl-L-Leucine for GM2 Gangliosidosis (Tay-Sachs and Sandhoff Disease)
- phase2N-Acetyl-L-Leucine for Niemann-Pick Disease, Type C (NPC)
🐶 Hiring Signal
News
no news has mentioned this company yet
comments(0)
5-min edit window · permanent after that